Schedule 13G ownership disclosure

Atara Biotherapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 046513206

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Redmile Group, LLC

    Shares: 601,243.00 · Class: 9.9%

  • Jeremy C. Green

    Shares: 601,243.00 · Class: 9.9%

  • RedCo I, L.P.

    Shares: 347,442.00 · Class: 5.8%

  • Redmile Biopharma Investments II, L.P.

    Shares: 302,173.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-049700
Form type
SCHEDULE 13G/A
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub